Want to create an interactive transcript for this episode?
Podcast: Johns Hopkins Kimmel Cancer Center
Episode: Cancer Matters with Dr Bill Nelson - FDA Approval of a Drug Targeting a Brain Cancer Mutation
Description: Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here